Philips' sees tariffs impact of 150-200 million euros after US-EU deal

Philips (PHG.AS) has lowered its estimated import tariff impact to €150-200 million, down from a previous €250-300 million, following the US-EU agreement on a 15% rate. Concurrently, the healthcare technology firm raised its core profit (EBITA) margin forecast to 11.3%-11.8% and reported a strong Q2 adjusted EBITA margin of 12.4%, significantly exceeding analyst expectations of 9.9%. This improved outlook and performance, coupled with a 6% growth in comparable order intake driven by innovations like AI-enabled diagnostic systems, signals robust operational execution and demand in its key healthcare segments.

Analysis

Philips (PHG.AS) has presented a materially improved financial outlook, driven by a combination of external tariff relief and strong operational execution. The company has lowered its estimated negative impact from US-EU import tariffs by approximately €100 million to a new range of €150-200 million, directly de-risking a significant headwind. This development, coupled with robust internal performance, has prompted an upward revision of its full-year core profit (EBITA) margin forecast to 11.3%-11.8%. The credibility of this guidance is strongly supported by second-quarter results, where the adjusted EBITA margin reached 12.4%, substantially outperforming the 9.9% analyst consensus. While quarterly sales of €4.3 billion were in line with expectations, the 6% growth in comparable order intake signals strong underlying demand. This growth is linked to innovation in high-margin areas, such as its AI-enabled diagnostic systems and a new long-term contract in Indonesia, underscoring the company's strong market position in advanced healthcare technology.

Key Decisions for Investors

• Investors should consider the concurrent upward revision to profit guidance and reduction in tariff impact as a strong bullish signal for Philips' near-term profitability.
• Attention should be focused on the sustainability of the high EBITA margins and the continued momentum in the 6% order intake growth, which serves as a key forward-looking indicator of demand for its innovative products.
• While the immediate trade risk has been mitigated, investors should remain cognizant that the tariff environment is described as 'dynamic' and could still introduce future volatility.